Is There Any Reason As To Why The Zai Lab (ZLAB) Stock Expanded By 13%?

The biopharmaceutical business Zai Lab Limited (NASDAQ: ZLAB), which is scheduled to announce its financial results next week, has increased 13.29% to $25.24 in current market price as of the most recent check on Tuesday.

Here's Your FREE Report on the #1 Small-Cap Uranium Stock of '24.

Small-cap Uranium stocks are booming in 2024! The company we're about to show you is the ONLY small-cap stock in the space that benefits from ALL aspects of the global Uranium industry with none of the risks of running a mine. Smart investors will not be hesitating on this one!

Get the FREE Report with all the details here.


When will ZLAB make the financials public?

Following the close of the U.S. equities markets on November 9, 2022, Zai Lab (ZLAB) will release its financial results and corporate updates for the three months that concluded on September 30, 2022. On November 10, 2022, at 8:00 a.m. ET, Zai Lab will conduct a live conference call and webcast.

By going to the investor part of the ZLAB website, listeners may have access to the live webcast. A replay of the call will also be made accessible immediately after it ends through the company website.

A busy month for ZLAB:

This month, ZLAB will attend the following conferences:

  • In November, management from Zai Lab will attend the following investment conferences:
  • At the Goldman Sachs Asia Pacific Healthcare Forum 2022 on Tuesday, November 15, 2022 at 9:30 a.m. HKT, ZLAB will take part in a panel discussion.
  • On Wednesday, November 16, 2022, ZLAB will also attend meetings at the Morgan Stanley 21st Annual Asia Pacific Summit in Singapore.
  • On Thursday, November 17, 2022, at 1:30 PM GMT, ZLAB will take part in a fireside conversation at the Jefferies London Healthcare Conference.
  • ZLAB will also participate in a number of sessions starting on November 5, 2022, through December 30, 2022, at the BioCentury-BayHelix East-West Summit in 2022.

Launch of the ZLAB Trust Report:

Zai Lab also released its 2022 Trust Report last month. Zai Lab is aware of how critical it is to earn and keep the confidence of the many parties we serve, including patients, staff, healthcare professionals, communities, and investors. ZLAB aspires to gain that confidence, in part, through its ESG approach and its dedication to enhancing human health, producing better results, and taking immediate action.

How is ZLAB changing things?

The Zai Lab (ZLAB) staff is dedicated to gaining trust through all they do every day. Many individuals may depend on one or multiple Zai drugs for long-term advantages, and ZLAB is aware of this. As a result, ZLAB wants to ensure that it earns and keeps its confidence over the course of its lifetime.